SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950144-08-007037
Filing Date
2008-09-12
Accepted
2008-09-12 13:11:18
Documents
8
Period of Report
2008-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CATALYST PHARMACEUTICAL PARTNERS, INC. g15077e8vk.htm 8-K 15385
2 EX-5.1 OPINION OF AKERMAN SENTERFITT g15077exv5w1.htm EX-5.1 7130
3 EX-10.1 ENGAGEMENT LETTER g15077exv10w1.htm EX-10.1 91626
4 EX-10.2 FORM OF SECURITIES PURCHASE AGREEMENT g15077exv10w2.htm EX-10.2 120120
5 EX-99.1 PRESS RELEASE g15077exv99w1.htm EX-99.1 8835
6 GRAPHIC g15077g15077e02.gif GRAPHIC 4696
7 GRAPHIC g15077g1507701.gif GRAPHIC 12199
8 GRAPHIC g15077g15077e01.gif GRAPHIC 4111
  Complete submission text file 0000950144-08-007037.txt   274065
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 081068798
SIC: 2834 Pharmaceutical Preparations